According to the drug's prescribing information, these potential risks are: An allergic reaction (hypersensitivity) Severe low blood sugar in people with type 2 diabetes, especially those taking insulin or sulfonylureas Complications related to diabetic retinopathy in those with type 2 diabetes Acute pancreatitis or gallbladder disease Acute kidney injury Increases in heart rate Suicidal ideation or behavior Lastly, Wegovy may increase the risk of certain thyroid tumors but this has only been observed in rodent studies
It is a glucagon-like peptide-1 (GLP-1) receptor agonist that helps improve glycemic control, delay gastric emptying, and reduce appetite by lowering glucagon secretion
Results May Vary: Individual results will vary based on factors including age, baseline health condition, starting weight, BMI, metabolic factors, consistency of use, genetic factors, current medications, lifestyle choices, dietary habits, physical activity level, and other individual variables
Such changes may indicate excessive muscle loss that requires intervention
How a drug for diabetes and obesity may help heal the liver The director of VCUs liver institute says a substance found in medications like Wegovy and Ozempic can address not only metabolic issues facing patients with liver disease but the liver disease itself
Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products-induced inflammation
